Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy BP (BP.) by Edward Sheldon in The Motley Fool
- Buy Severn Trent (SVT) by Bank of America
- Buy Smith & Nephew (SN.) by Edward Sheldon in The Motley Fool
- Buy Diageo (DGE) by Edward Sheldon in The Motley Fool
- Buy Ocado Group (OCDO) by Edward Sheldon in The Motley Fool
- Buy National Grid (NG.) by James Beard in The Motley Fool
- Buy Legal & General Group (LGEN) by Dr. James Fox in The Motley Fool
- Buy Hargreaves Lansdown (HL.) by Dr. James Fox in The Motley Fool
- Watch Abrdn (ABDN) by Jon Smith in The Motley Fool
- Watch Close Brothers Group (CBG) by Jon Smith in The Motley Fool
- Watch British Land Company (BLND) by Jon Smith in The Motley Fool
- Watch Primary Health Properties (PHP) by Jon Smith in The Motley Fool
- Buy Jet2 (JET2) by Phil Oakley in The Telegraph - Questor
- Hold M&G (MNG) by Deutsche Bank
- Buy PZ Cussons (PZC) by Deutsche Bank
- Outperform Kingfisher (KGF) by RBC Capital
- Outperform Watches of Switzerland Group (WOSG) by RBC Capital
- Overweight Reckitt Benckiser Group (RKT) by Barclays
- Equal Weight Relx plc (REL) by Barclays
- Hold BT Group (BT.A) by Berenberg
Hikma Pharmaceuticals (HIK) Share Price
Health Care Sector
Members only
To view this content and much more please Sign Up
NOTE: This is based on 326 open tips for Hikma Pharmaceuticals (HIK)
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Hikma Pharmaceuticals (HIK) Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Hikma Pharmaceuticals (HIK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | RBC Capital | – | 2023-09-06 05:57:00 06/09/2023 | – |
| – | Dr. James Fox | – | 2023-08-27 09:00:00 27/08/2023 | – |
| – | JP Morgan | – | 2023-08-18 06:04:00 18/08/2023 | – |
| – | Berenberg | – | 2023-08-04 06:18:00 04/08/2023 | – |
| – | Barclays | – | 2023-07-12 06:35:00 12/07/2023 | – |
Hikma Pharmaceuticals (HIK) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| Millennium International Management LP | 0.52% | 11/09/2023 |
| WorldQuant LLC | 0.59% | 17/10/2022 |
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Hikma Pharmaceuticals Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Hikma Pharmaceuticals Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | RBC Capital | – | 2023-09-06 05:57:00 06/09/2023 | – |
| – | Dr. James Fox | – | 2023-08-27 09:00:00 27/08/2023 | – |
| – | JP Morgan | – | 2023-08-18 06:04:00 18/08/2023 | – |
| – | Berenberg | – | 2023-08-04 06:18:00 04/08/2023 | – |
| – | Barclays | – | 2023-07-12 06:35:00 12/07/2023 | – |